Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | DHFR | P00374 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30142113 | 1.00 | ALOX5 (0.65) | ALOX5MAPTDHFRALDH1A1KDM4E | |
| SCHEMBL14665143 | 0.91 | ALOX5 (0.57) | ALOX5MAPTDHFRALDH1A1KDM4E | |
| SCHEMBL12364825 | 0.88 | ALOX5 (0.55) | ALOX5MAPTDHFRALDH1A1KDM4E | |
| SCHEMBL25895033 | 0.88 | ALOX5 (0.62) | ALOX5MAPTDHFRALDH1A1KDM4E | |
| SCHEMBL12223406 | 0.88 | ALOX5 (0.57) | ALOX5MAPTDHFRALDH1A1KDM4E | |
| SCHEMBL29473526 | 0.88 | ALOX5 (0.57) | ALOX5MAPTDHFRALDH1A1KDM4E | |
| SCHEMBL19608965 | 0.85 | DHFR (0.57) | ALOX5MAPTDHFRALDH1A1KDM4E | |
| SCHEMBL1807916 | 0.85 | ALOX5 (0.50) | ALOX5MAPTDHFRALDH1A1KDM4E | |
| SCHEMBL2048172 | 0.85 | MAPT (0.58) | ALOX5MAPTGAATDP1L3MBTL1 | |
| SCHEMBL8108637 | 0.84 | ALOX5 (0.60) | ALOX5MAPTDHFRALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192950-A1 | THERMOPLASTIC RESIN AND OPTICAL MEMBER | TEIJIN LIMITED (JP) | 2023-06-22 | — | — | US | disclosed |
| US-20230192950-A1 | THERMOPLASTIC RESIN AND OPTICAL MEMBER | TEIJIN LIMITED (JP) | 2023-06-22 | — | — | US | disclosed |
| US-20230051676-A1 | POLYCARBONATE AND METHOD FOR PRODUCING POLYCARBONATE | TEIJIN LIMITED (JP) | 2023-02-16 | — | — | US | disclosed |
| US-20210371650-A1 | POLY(ESTER)CARBONATE AND METHOD FOR PRODUCING POLY(ESTER)CARBONATE | TEIJIN LIMITED (JP) | 2021-12-02 | — | — | US | disclosed |
| US-8344080-B2 | Catalyst for olefin polymerization and method of preparation thereof | WANG LICAI (CN) | 2013-01-01 | — | — | US | disclosed |
| US-20110301385-A1 | CATALYST FOR OLEFIN POLYMERIZATION AND METHOD OF PREPARATION THEREOF | WANG LICAI (CN) | 2011-12-08 | — | — | US | disclosed |
| US-8003816-B2 | Bisphosphite ligands for hydroformylation catalyzed by transition metals | EVONIK OXENO GMBH (DE) | 2011-08-23 | — | — | US | disclosed |
| US-7964678-B2 | Comprises titanium/magnesium-1,4-diether [2,2'-dialkoxy-1,1'-biphenyl, 2,2'-dialkoxy-1,1'-binaphthalene, 10,10'-dialkoxy-9,9-biphenanthrene complex, organoaluminum compound, and organosilicon compound; molecular weight control | WANG LICAI | 2011-06-21 | — | — | US | disclosed |
| US-20110071321-A1 | METHOD FOR SEPERATING 1-BUTENE FROM C4-CONTAINING HYDROCARBON STREAMS BY HYDROFORMYLATION | EVONIK OXENO GMBH (DE) | 2011-03-24 | — | — | US | disclosed |
| US-20100036143-A1 | BISPHOSPHITE LIGANDS FOR HYDROFORMYLATION CATALYZED BY TRANSITION METALS | EVONIK OXENO GMBH (DE) | 2010-02-11 | — | — | US | disclosed |
| US-20080161513-A1 | Catalyst for Olefin Polymerization and Preparation Thereof and Polymerization Process | YINGKOU XIANGYANG CATALYST CO., LTD. (CN) | 2008-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100036143-A1 | BISPHOSPHITE LIGANDS FOR HYDROFORMYLATION CATALYZED BY TRANSITION METALS | SLC9B2, CTR9, POF1B | ALOX5 352/4885MAPT 4861/4885DHFR 1284/4885 |
| US-20110071321-A1 | METHOD FOR SEPERATING 1-BUTENE FROM C4-CONTAINING HYDROCARBON STREAMS BY HYDROFORMYLATION | SLC9B2, INTS9, C9 | ALOX5 673/4885MAPT 4837/4885DHFR 2101/4885 |
| US-20110301385-A1 | CATALYST FOR OLEFIN POLYMERIZATION AND METHOD OF PREPARATION THEREOF | PPOX, CAT, POR | ALOX5 18/4885MAPT 2740/4885DHFR 185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.